Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Avitas Wealth Management LLC

Avitas Wealth Management LLC cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.3% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,866 shares of the medical equipment provider’s stock after selling 43 shares during the period. Avitas Wealth Management LLC’s holdings in Intuitive Surgical were worth $974,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Bennett Selby Investments LP raised its holdings in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after purchasing an additional 17 shares in the last quarter. LVW Advisors LLC raised its stake in Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after buying an additional 19 shares in the last quarter. Wesbanco Bank Inc. lifted its holdings in Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after buying an additional 19 shares during the last quarter. FSM Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after acquiring an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC increased its holdings in shares of Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock valued at $542,000 after acquiring an additional 19 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares in the company, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 28,843 shares of company stock valued at $15,357,560. Corporate insiders own 0.80% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Leerink Partners upped their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. CICC Research assumed coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Finally, Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Up 0.2 %

Shares of NASDAQ:ISRG opened at $579.65 on Wednesday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company has a 50-day moving average price of $551.24 and a 200 day moving average price of $511.16. The company has a market cap of $206.46 billion, a P/E ratio of 90.43, a PEG ratio of 5.51 and a beta of 1.39.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.